X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (629) 629
Book Chapter (8) 8
Publication (4) 4
Conference Proceeding (3) 3
Book / eBook (2) 2
Streaming Audio (2) 2
Book Review (1) 1
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (324) 324
life sciences & biomedicine (315) 315
humans (240) 240
cardiovascular system & cardiology (190) 190
cardiac & cardiovascular systems (161) 161
male (143) 143
female (126) 126
aged (111) 111
middle aged (99) 99
risk factors (79) 79
diabetes (67) 67
endocrinology & metabolism (63) 63
peripheral vascular disease (59) 59
cardiology (58) 58
cardiovascular (55) 55
abridged index medicus (53) 53
cardiovascular disease (50) 50
diabetes mellitus (49) 49
animals (48) 48
treatment outcome (47) 47
analysis (43) 43
atherosclerosis (41) 41
cardiovascular diseases (40) 40
internal medicine (39) 39
aged, 80 and over (38) 38
inflammation (38) 38
medicine & public health (37) 37
mortality (37) 37
adult (34) 34
cardiology and cardiovascular medicine (34) 34
diabetes mellitus, type 2 - drug therapy (34) 34
general & internal medicine (34) 34
prospective studies (34) 34
medicine, general & internal (32) 32
hypoglycemic agents - therapeutic use (31) 31
type 2 diabetes (31) 31
patients (30) 30
prognosis (29) 29
care and treatment (28) 28
echocardiography (28) 28
research (27) 27
coronary artery disease (26) 26
cells, cultured (25) 25
heart failure (25) 25
predictive value of tests (25) 25
time factors (25) 25
biomarkers - blood (24) 24
heart attacks (24) 24
coronary heart disease (23) 23
health aspects (22) 22
heart diseases (22) 22
myocardial infarction (22) 22
risk assessment (21) 21
cardiac patients (20) 20
hematology (20) 20
mice (20) 20
coronary angiography (19) 19
follow-up studies (19) 19
insulin resistance (19) 19
severity of illness index (19) 19
electrocardiography (18) 18
type 2 diabetes mellitus (18) 18
diabetes mellitus, type 2 - complications (17) 17
germany (17) 17
heart (17) 17
rats (17) 17
glucose (16) 16
incidence (16) 16
physiological aspects (16) 16
retrospective studies (16) 16
cell biology (15) 15
coronary vessels (15) 15
medical research (15) 15
original investigation (15) 15
stroke (15) 15
arteriosclerosis (14) 14
calcification (14) 14
clinical trials (14) 14
double-blind method (14) 14
magnetic resonance imaging (14) 14
medicine (14) 14
radiology, nuclear medicine & medical imaging (14) 14
studies (14) 14
usage (14) 14
angina pectoris (13) 13
blood glucose - metabolism (13) 13
cardiovascular diseases - prevention & control (13) 13
diabetics (13) 13
peptides (13) 13
reproducibility of results (13) 13
thiazolidinediones (13) 13
cardiovascular diseases - epidemiology (12) 12
cardiovascular diseases - mortality (12) 12
cerebral infarction (12) 12
coronary artery disease - diagnosis (12) 12
diabetes mellitus, type 2 - blood (12) 12
drug therapy (12) 12
heart failure - physiopathology (12) 12
heart valve diseases (12) 12
hypoglycemic agents - adverse effects (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American journal of cardiology, ISSN 0002-9149, 07/2017, Volume 120, Issue 1, pp. S37 - S47
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2011, Volume 58, Issue 23, pp. 2357 - 2362
Journal Article
European heart journal, ISSN 0195-668X, 03/2020, Volume 41, Issue 35, pp. 3359 - 3362
Journal Article
European heart journal, ISSN 1522-9645, 11/2016, Volume 37, Issue 42, pp. 3192 - 3200
Journal Article
European heart journal, ISSN 0195-668X, 04/2010, Volume 31, Issue 8, pp. 957 - 957
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2018, Volume 321, Issue 1, pp. 69 - 79
IMPORTANCE: Type 2 diabetes is associated with increased cardiovascular (CV) risk. Prior trials have demonstrated CV safety of 3 dipeptidyl peptidase 4 (DPP-4)... 
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - mortality | Cardiovascular Diseases - etiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Risk Factors | Linagliptin - adverse effects | Proportional Hazards Models | Male | Linagliptin - therapeutic use | Glycated Hemoglobin A | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemia - chemically induced | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Vascular diseases | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Index Medicus | Abridged Index Medicus | Online First | Original Investigation
Journal Article
The American journal of medicine, ISSN 0002-9343, 06/2017, Volume 130, Issue 6, pp. S40 - S50
Epidemiologic and clinical data from the last 2 decades have shown that the prevalence of heart failure in diabetes is very high, and the prognosis for... 
Life Sciences & Biomedicine | Medicine, General & Internal | General & Internal Medicine | Science & Technology
Journal Article
Gut, ISSN 0017-5749, 01/2019, Volume 68, Issue 1, pp. 25 - 39
ObjectiveVedolizumab, a monoclonal antibody directed against the integrin heterodimer α4β7, is approved for the treatment of Crohn’s disease and ulcerative... 
integrins | Crohn's disease | ulcerative colitis | inflammatory bowel disease | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Immunohistochemistry | Inflammatory Bowel Diseases - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Immunity, Innate - drug effects | Humans | Inflammatory Bowel Diseases - immunology | Tomography, Emission-Computed, Single-Photon | Immunophenotyping | Male | Infliximab - therapeutic use | Case-Control Studies | Phenotype | Adaptive Immunity - drug effects | Sequence Analysis, RNA | Biopsy | Gastrointestinal Agents - therapeutic use | Adult | Female | T-Lymphocytes - immunology | Integrins - antagonists & inhibitors | Inflammatory bowel diseases | Mucosal immunity | Mucosa | Innate immunity | Lymphocytes T | Macrophages | Cell adhesion & migration | T-cell receptor | Leucocytes | Infliximab | Computed tomography | Intestine | Lymphocytes | Rodents | Gastroenterology | Colon | Phenotypes | Lymphatic system | Lamina propria | Inflammation | T cell receptors | Adaptive immunity | Tumor necrosis factor-α | Ribonucleic acid--RNA | Patients | Single photon emission computed tomography | Investigations | Economic statistics | Inflammatory bowel disease | Algorithms | Monoclonal antibodies | Ligands | Ulcerative colitis | Index Medicus | Abridged Index Medicus
Journal Article